The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-((4-((5-cyclopropyl-1H-pyrazol-3-yl)amino)pyrimidin-2-yl)amino)phenyl)acetonitrile ID: ALA1235645
Chembl Id: CHEMBL1235645
Max Phase: Preclinical
Molecular Formula: C18H17N7
Molecular Weight: 331.38
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: N#CCc1ccc(Nc2nccc(Nc3cc(C4CC4)[nH]n3)n2)cc1
Standard InChI: InChI=1S/C18H17N7/c19-9-7-12-1-5-14(6-2-12)21-18-20-10-8-16(23-18)22-17-11-15(24-25-17)13-3-4-13/h1-2,5-6,8,10-11,13H,3-4,7H2,(H3,20,21,22,23,24,25)
Standard InChI Key: YRRRHSNOXWKVDL-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 331.38Molecular Weight (Monoisotopic): 331.1545AlogP: 3.63#Rotatable Bonds: 6Polar Surface Area: 102.31Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.84CX Basic pKa: 4.29CX LogP: 3.42CX LogD: 3.42Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.64Np Likeness Score: -1.40
References 1. Amrhein JA, Wang G, Berger BT, Berger LM, Kalampaliki AD, Krämer A, Knapp S, Hanke T.. (2023) Design and Synthesis of Pyrazole-Based Macrocyclic Kinase Inhibitors Targeting BMPR2., 14 (6): [PMID:37312836 ] [10.1021/acsmedchemlett.3c00127 ]